Claudius Speer, Florian Kälble, Luiza Pego da Silva, Christian Nusshag, Matthias Schaier, Luis E Becker, Katrin Klein, Jörg Beimler, Claudia Sommerer, Albrecht Leo, Caner Süsal, Arianeb Mehrabi, Martin Zeier, Christian Morath
OBJECTIVE: In recent studies, semi-selective compared to antigen-specific immunoadsorption (IA) columns showed comparable effectiveness in anti-A/B antibody removal before incompatible living donor kidney transplantation. Semi-selective columns allow a greater number of IA treatments at lower costs. They are also capable of removing potentially harmful human leukocyte antigen alloantibodies. Nevertheless, additional plasma exchange treatments are often necessary to reach the preoperative target titer, most likely due to an inadequate anti-A/B IgM antibody depletion...
August 17, 2019: Atherosclerosis. Supplements